LIF Antibodies

Santa Cruz Biotechnology features a diverse variety of LIF Antibodies for investigating leukemia inhibitory factor (LIF) in various biological processes. LIF Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA) applications.LIF is a cytokine that plays a crucial role in cell differentiation, survival, and proliferation, particularly in stem cell maintenance and immune response regulation. The significance of LIF extends to various physiological and pathological processes, including embryonic development and cancer progression. Research focused on LIF can provide insights into therapeutic strategies for numerous diseases. Monoclonal LIF antibodies enable precise detection and analysis of LIF expression patterns across different tissue types. Understanding LIF signaling pathways helps reveal molecular mechanisms underlying stem cell biology and immune system function. Investigating LIF activity contributes to advancing knowledge in developmental biology and potential cancer treatments. Santa Cruz Biotechnology monoclonal LIF antibodies support researchers worldwide in advancing scientific understanding of this important cytokine's role in health and disease.